- Neurologic disease burden in treated HIV/AIDS predicts survival A population-based study
[作者：Vivithanaporn, P; Heo, G; Gamble, J; Krentz, HB; Hoke, A; Gill, MJ; Power, C,期刊：Neurology, 页码：1150-1158 , 文章类型： Article，,卷期：2010年75-13]
- Background: Combination antiretroviral therapy (cART) has improved the survival of patients with HIV/AIDS but its impact remains uncertain on the changing prevalence and incidence of neurologic disorders with ensuing eff...
- Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations
[作者：Deprez, L; Weckhuysen, S; Holmgren, P; Suls, A; Van Dyck, T; Goossens, D; Del-Favero, J; Jansen, A; Verhaert, K; Lagae, L; Jordanova, A; Van Coster, R; Yendle, S; Berkovic, SF; Scheffer, I; Ceulemans, B; De Jonghe, P,期刊：Neurology, 页码：1159-1165 , 文章类型： Article，,卷期：2010年75-13]
- Objectives: Heterozygous mutations in STXBP1, encoding the syntaxin binding protein 1, have recently been identified in Ohtahara syndrome, an epileptic encephalopathy with very early onset. In order to explore the phenot...
- Pilot pharmacologic randomized controlled trial for psychogenic nonepileptic seizures
[作者：LaFrance, WC; Keitner, GI; Papandonatos, GD; Blum, AS; Machan, JT; Ryan, CE; Miller, IW,期刊：Neurology, 页码：1166-1173 , 文章类型： Article，,卷期：2010年75-13]
- Objective: There have been few treatment trials for psychogenic nonepileptic seizures (PNES). Some psychotherapies have been shown to improve PNES and comorbid symptom outcomes. We evaluated a pharmacologic intervention ...
- Motor activation in multiple system atrophy and Parkinson disease A PET study
[作者：Payoux, P; Brefel-Courbon, C; Ory-Magne, F; Regragui, W; Thalamas, C; Balduyck, S; Durif, F; Azulay, JP; Tison, F; Blin, O; Esquerre, JP; Rascol, O,期刊：Neurology, 页码：1174-1180 , 文章类型： Article，,卷期：2010年75-13]
- Background: Multiple system atrophy (MSA) is an atypical parkinsonian syndrome including cerebellar impairment and poor response to levodopa. We assessed right hand motor activation in patients with MSA before and after ...
- Mutations in SACS cause atypical and late-onset forms of ARSACS
[作者：Baets, J; Deconinck, T; Smets, K; Goossens, D; Van den Bergh, P; Dahan, K; Schmedding, E; Santens, P; Rasic, VM; Van Damme, P; Robberecht, W; De Meirleir, L; Michielsens, B; Del-Favero, J; Jordanova, A; De Jonghe, P,期刊：Neurology, 页码：1181-1188 , 文章类型： Article，,卷期：2010年75-13]
- Background: Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a complex neurodegenerative disorder caused by mutations in SACS. The phenotype consists of a childhood-onset triad of cerebellar ataxia, ...
- A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2
[作者：Kay, DM; Stevens, CF; Hamza, TH; Montimurro, JS; Zabetian, CP; Factor, SA; Samii, A; Griffith, A; Roberts, JW; Molho, ES; Higgins, DS; Gancher, S; Moses, L; Zareparsi, S; Poorkaj, P; Bird, T; Nutt, J; Schellenberg, GD; Payami, H,期刊：Neurology, 页码：1189-1194 , 文章类型： Article，,卷期：2010年75-13]
- Objectives: To perform a comprehensive population genetic study of PARK2. PARK2 mutations are associated with juvenile parkinsonism, Alzheimer disease, cancer, leprosy, and diabetes mellitus, yet ironically, there has be...
- Diabetes, Alzheimer disease, and vascular dementia A population-based neuropathologic study
[作者：Ahtiluoto, S; Polvikoski, T; Peltonen, M; Solomon, A; Tuomilehto, J; Winblad, B; Sulkava, R; Kivipelto, M,期刊：Neurology, 页码：1195-1202 , 文章类型： Article，,卷期：2010年75-13]
- Objective: To investigate the relation of diabetes to dementia, Alzheimer disease (AD), and vascular dementia (VaD), through analyses of incidence, mortality, and neuropathologic outcomes in a prospective population-base...
- Nonsteroidal anti-inflammatory drugs are associated with increased neuritic plaques
[作者：Sonnen, JA; Larson, EB; Walker, RL; Haneuse, S; Crane, PK; Gray, SL; Breitner, JCS; Montine, TJ,期刊：Neurology, 页码：1203-1210 , 文章类型： Article，,卷期：2010年75-13]
- Objectives: Observational and experimental studies suggest that nonsteroidal anti-inflammatory drugs (NSAIDs) may protect against Alzheimer disease (AD); however, clinical trials and other observational studies, includin...
- AAN guidelines A benefit to the neurologist
[作者：Getchius, TSD; Moses, LK; French, J; Gronseth, GS; England, JD; Miyasaki, J,期刊：Neurology, 页码：1126-1127 , 文章类型： Editorial Material，,卷期：2010年75-13]
-
- EVOLUTION OF A TUMOR-LIKE LESION IN CEREBRORETINAL VASCULOPATHY AND TREX1 MUTATION
[作者：Mateen, FJ; Krecke, K; Younge, BR; Ford, AL; Shaikh, A; Kothari, PH; Atkinson, JP,期刊：Neurology, 页码：1211-1213 , 文章类型： Editorial Material，,卷期：2010年75-13]
-
|